U.S. Markets open in 1 hr 16 mins

Retrophin, Inc. (RTRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
16.90-0.13 (-0.76%)
At close: 4:00PM EDT
People also watch
SAGEPRTARAREFPRXRVNC
Interactive chart
Previous Close17.03
Open17.12
Bid0.01 x 100
Ask0.00 x
Day's Range16.65 - 17.16
52 Week Range15.88 - 24.57
Volume326,494
Avg. Volume375,803
Market Cap645.13M
Beta1.25
PE Ratio (TTM)-9.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube11 days ago

    ETFs with exposure to Retrophin, Inc. : May 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Retrophin, Inc. Here are 5 ETFs with the largest exposure to RTRX-US. Comparing the performance and risk of Retrophin, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents12 days ago

    Edited Transcript of RTRX earnings conference call or presentation 4-May-17 8:30pm GMT

    Q1 2017 Retrophin Inc Earnings Call

  • Retrophin, Inc. :RTRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube13 days ago

    Retrophin, Inc. :RTRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis Retrophin, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Retrophin, Inc. – Sarepta Therapeutics, Inc., PTC Therapeutics, Inc., Novartis AG Sponsored ADR, Pfizer Inc., Acceleron Pharma Inc, Intercept Pharmaceuticals, Inc. and Lannett Company, Inc. (SRPT-US, PTCT-US, NVS-US, PFE-US, ... Read more (Read more...)